Topic: Flccc

The FLCCC movement is highlighted as an alternative to a "sick care" system that prioritizes patented drugs over effective early treatments. Meanwhile, a veterinary crisis is emerging in Texas as multi-drug resistant tuberculosis jumps from migrant populations to dairy cattle. Dr. Michael Vickers warns that Texas is at risk of losing its TB-free status, which would have catastrophic implications for the agricultural economy.

The host and Dr. McCullough discuss the rise of "medical freedom" and the importance of patients finding doctors who are willing to use alternative treatments like Budesonide and Ivermectin. They criticize the standard NIH hospital protocols, which they claim led to unnecessary deaths on ventilators. Organizations like the FLCCC and the Association of American Physicians and Surgeons are recommended as resources for finding doctors who have "come clean" about vaccine risks.

Registered nurse Nicole Sirotek testifies about her experience in New York City hospitals during the start of the pandemic. She alleges that many patients died from medical mismanagement and negligence rather than COVID-19. Sirotek specifically criticizes the use of Remdesivir, claiming it was "rolled out" onto disadvantaged populations despite evidence of its toxicity and lethal side effects.

For those suffering from "Long Hauler" syndrome, Dr. McCullough recommends the FLCCC "I-Recover" protocol, which utilizes ivermectin to antagonize the spike protein. He also mentions fluvoxamine as a drug showing promise in reducing the severity of neurologic symptoms and inflammation. McCullough emphasizes that while these are not yet proven in large randomized trials, they offer a conceptual framework for treating persistent spike protein damage.

Dr. Brian Ardis joins the studio to reveal a document on the NIH website (Table 2E) that lists Ivermectin as an approved antiviral agent for the treatment of COVID-19. He argues that despite mainstream media claims that it is only "horse dewormer," the NIH's own chart includes Ivermectin dosing protocols. Ardis encourages families to print this document to challenge hospital administrators who refuse to administer the drug.

Scott Miller recounts a specific intervention in Portland where a patient was successfully treated with high-dose methylprednisolone and antibiotics for a secondary bacterial pneumonia. Despite the patient's rapid improvement, Miller claims the hospital refused to credit the alternative treatments and attempted to return the patient to standard dexamethasone protocols. The FLCCC Alliance is cited as a resource for these alternative treatment protocols.